| (CCTG) HN.10 / EVADER | A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-risk HPV-related Oropharyngeal Squamous Cell Carcinoma | Lee, Dr Justin | Open to recruitment | NCT03822897 |
| (CCTG) HN.9/LA-OSCC | Randomized Phase II Study of Cisplatin plus Radiotherapy versus Durvalumab plus Radiotherapy followed by Adjuvant Durvalumab versus Durvalumab plus Radiotherapy followed by Adjuvant Tremelimumab and Durvalumab in Intermediate Risk HPV-Positive Locoregionally Advanced Oropharyngeal Squamous Cell Cancer (LA-OSCC) | Meyers, Dr Brandon | Open to recruitment | NCT03410615 |
| (JCC) SHINE / HNSBRT | A Phase 2 Study of SBRT for Squamous Cell Carcinoma of the Head and Neck | Lee, Dr Justin | Open to recruitment | NCT04435938 |
| (LHRI) RADIO/Cisplatin Hearing Loss/Cisplatin HD vs LD | Randomized Assessment of Cisplatin Dosing Interval for Ototoxicity in the treatment of locally advanced head and neck squamous cell carcinoma (LAHNSCC) undergoing curative concurrent chemoradiotherapy (RADIO) | Meyers, Dr Brandon | Open to recruitment | NCT03649048 |
Find a Trial
Contact Us